Reirradiation and concomitant metronomic temozolomide: An efficient combination for local control in medulloblastoma disease?

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 8, 2011, Pages 600-604

  Padovani, Laetitia ^a   Andre, Nicolas ^a   Gentet, Jean Claude ^a   Figarella Branger, Dominique ^a   Scavarda, Didier ^a   Verschuur, Arnaud ^a   Chinot, Olivier ^a   Cowen, Didier ^a   Muracciole, Xavier ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CELECOXIB; CISPLATIN; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; ETOPOSIDE; GEMCITABINE; IRINOTECAN; OXALIPLATIN; RETINOIC ACID; TEMOZOLOMIDE; THIOTEPA; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RELAPSE; CHEMORADIOTHERAPY; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONFORMAL REIRRADIATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NEUROTOXICITY; PATIENT CARE; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; RADIOSENSITIZATION; SCHOOL CHILD; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR RECURRENCE;

ADMINISTRATION, METRONOMIC; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; CHILD; DACARBAZINE; FATAL OUTCOME; FEMALE; HUMANS; MALE; MEDULLOBLASTOMA; RADIATION DOSAGE; RETREATMENT; YOUNG ADULT;

EID: 80455125814     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182331eaf     Document Type: Article

References (25)

1. Dunkel IJ, Gardner SL, Garvin JH Jr., et al. High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma. Neurol Oncol. 2010;12:297-303.
2. Massimino M, Gandola L, Spreafico F, et al. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma. Int J Radiat Oncol Biol Phys. 2009;73:1358-1363.
3. Finlay JL. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors. Bone Marrow Transplant. 1996;18(Suppl 3):S1-S5.
4. Finlay JL, Goldman S, Wong MC, et al. Pilot study of highdose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors: The Children's Cancer Group. J Clin Oncol. 1996;14: 2495-2503.
5. Pasquier E, Kavallaris M, Andre N. Metronomic chemotherapy: New rationale for new directions. Nat Rev Clin Oncol. 2010;7:455-465.
6. Sterba J, Pavelka Z, Andre N, et al. Second complete remission of relapsed medulloblastoma induced by metronomic chemotherapy. Pediatr Blood Cancer. 2010;54:616-617.
7. Nicholson HS, Kretschmar CS, Krailo M, et al. Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: A report from the Children's Oncology Group. Cancer. 2007;110:1542-1550.
8. van Rijn J, Heimans JJ, van den BJ, et al. Survival of human glioma cells treated with various combination of temozolomide and x-rays. Int J Radiat Oncol Biol Phys. 2000;47:779-784.
9. Stupp R, Dietrich PY, Ostermann KS, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol. 2002;20: 1375-1382.
10. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol. 2009;10:459-466.
11. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al. Standardrisk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol. 2005;23:4726-4734.
12. Choi LM, Rood B, Kamani N, et al. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors. Pediatr Blood Cancer. 2008;50:970-975.
13. Verlooy J, Mosseri V, Bracard S, et al. Treatment of high risk medulloblastomas in children above the age of 3 years: A SFOP study. Eur J Cancer. 2006;42:3004-3014.
14. Gill P, Litzow M, Buckner J, et al. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system. Cancer. 2008;112:1805-1811.
15. Gururangan S, Krauser J, Watral MA, et al. Efficacy of highdose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. Neurol Oncol. 2008;10:745-751.
16. Sterba J, Pavelka Z, Slampa P. Concomitant radiotherapy and metronomic temozolomide in pediatric high-risk brain tumors. Neoplasma. 2002;49:117-120.
17. Loh KC, Willert J, Meltzer H, et al. Temozolomide and radiation for aggressive pediatric central nervous system malignancies. J Pediatr Hematol Oncol. 2005;27:254-258.
18. Lashford LS, Thiesse P, Jouvet A, et al. Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol. 2002;20:4684-4691.
19. Baruchel S, Diezi M, Hargrave D, et al. Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours. Eur J Cancer. 2006;42:2335-2342.
20. Schultheiss TE, Kun LE, Ang KK, et al. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys. 1995;31:1093-1112.
21. Veninga T, Langendijk HA, Slotman BJ, et al. Reirradiation of primary brain tumours: Survival, clinical response and prognostic factors. Radiother Oncol. 2001;59:127-137.
22. Abe M, Tokumaru S, Tabuchi K, et al. Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas. Pediatr Neurosurg. 2006;42:81-88.
23. Milker-Zabel S, Zabel A, Thilmann C, et al. Results of threedimensional stereotactically guided radiotherapy in recurrent medulloblastoma. J Neurooncol. 2002;60:227-233.
24. Bakst RL, Dunkel IJ, Gilheeney S, et al. Reirradiation for recurrent medulloblastoma. Cancer. 2011.
25. Wedge SR, Porteous JK, Glaser MG, et al. In vitro evaluation of temozolomide combined with X-irradiation. Anticancer Drugs. 1997;8:92-97.